CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B […]
Tubulis’ €60 Million Series B Financing Round
AndCompany GmbH’s Acquisition of ion2s GmbH
Greenfort advised the sellers. CMS advised Rigeto and newly formed holding company AndCompany. ion2s GmbH, with its seat in Darmstadt, announced the acquisition by AndCompany GmbH. After […]
Optimapharm d.o.o.’s Acquisition of SSS International Clinical Research GmbH
CMS advised Optimapharm d.o.o. on the deal. Croatian company Optimapharm d.o.o. has acquired SSS International Clinical Research GmbH. Optimapharm is an international contract research organisation (CRO) […]
FreshBooks’ Acquisition of FastBill
CMS advised FreshBooks on the deal, while DLA Piper advised the shareholders of FastBill. FreshBooks, a leading provider of cloud-based accounting software with customers in more […]
Afinum’s Acquisition Of A Majority Stake In Tisso Naturprodukte GmbH
CMS advised Afinum Achte Beteiligungsgesellschaft mbH & Co. KG on the deal. Afinum Achte Beteiligungsgesellschaft mbH & Co. KG, which is advised by Afinum Management GmbH, […]
PerkinElmer, Inc.’s Acquisition Of Sirion Biotech
CMS advised and represented the shareholders in SIRION BIOTECH on the deal. Listed US company PerkinElmer, Inc. has acquired SIRION BIOTECH, a leading global provider of […]
PerkinElmer, Inc.’s Acquisition Of SIRION BIOTECH GmbH
Hogan Lovells advised PerkinElmer, Inc. on the deal. CMS advised the shareholders in SIRION BIOTECH. PerkinElmer, Inc. acquired SIRION BIOTECH GmbH, a leading global provider of viral […]